Use of Artificial Hydration at the End of Life: A Survey of Australian and New Zealand Palliative Medicine Doctors

Journal of Palliative Medicine
Jacqueline Oehme, Caitlin Sheehan

Abstract

Dying is ubiquitous, yet the optimal management of hydration in the terminal phase is undetermined. Palliative care (PC) doctors' practices may act as a de facto measure of the benefits and burdens of artificial hydration (AH) use. To identify PC doctors' AH prescribing practices for imminently dying patients and possible influencing factors. An online survey of doctors belonging to the Australian and New Zealand Society of Palliative Medicine. One hundred and thirty-six surveys were completed (30% response rate). AH use for patients in the prognosticated last week of life was low: 77% of respondents prescribed AH to 0-10% of patients and 3% of respondents prescribed to more than 20%. The most common reason for prescribing AH was palliation of family/patient concern rather than a physical symptom. The majority thought there was no effect of AH on survival, or on symptoms of fatigue (90%), reduced level of consciousness (88%), agitation (75%), nausea (69%), vomiting (68%), myoclonus (66%), thirst (65%), delirium (62%), cough (57%), or bowel obstruction (50%). AH was thought to worsen subcutaneous edema (94%), upper respiratory tract secretions (85%), ascites (73%), physical discomfort (72%), dyspnea (62%), and urinary symptoms (...Continue Reading

References

Oct 1, 1993·Journal of Pain and Symptom Management·F I Burge
Jul 1, 1994·Journal of Pain and Symptom Management·R L FainsingerJ Hanson
Mar 1, 1996·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·E BrueraR L Fainsinger
May 1, 1997·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·R L Fainsinger, E Bruera
Apr 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G C RinckC H Veenhof
Feb 8, 2000·The American Journal of Hospice & Palliative Care·T MoritaS Chihara
Mar 16, 2000·Palliative Medicine·G E Grande, C J Todd
Nov 19, 2002·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·T-Y ChiuC-Y Chen
Dec 19, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tatsuya MoritaUNKNOWN Japan Palliative Oncology Study Group
Oct 1, 2003·Journal of Palliative Medicine·Tatsuya MoritaSatoshi Inoue
May 8, 2004·Journal of Palliative Medicine·Kathryn LanukeDonna DeMoissac
Dec 14, 2004·Journal of Palliative Medicine·Tatsuya MoritaUNKNOWN Japan Palliative Oncology Study Group
Feb 3, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T MoritaUNKNOWN Japan Palliative Oncology Study Group
Apr 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eduardo BrueraJ Lynn Palmer
Oct 22, 2005·Journal of Palliative Medicine·William M Plonk, Robert M Arnold
Nov 1, 2005·Journal of Pain and Symptom Management·Sebastiano MercadanteAlessandra Casuccio
Jul 3, 2007·The American Journal of Hospice & Palliative Care·Mitsunori MiyashitaIsamu Adachi
Nov 8, 2007·Evaluation & the Health Professions·Jonathan B VanGeestVerna L Welch
Apr 17, 2008·International Journal of Palliative Nursing·Pamela van der RietLudmilla Sneesby
Apr 15, 2009·Current Opinion in Supportive and Palliative Care·Shalini DalalEduardo Bruera
Nov 10, 2009·JPEN. Journal of Parenteral and Enteral Nutrition·Cynthia M A GeppertMary Ellen Druyan
Jan 5, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N J H RaijmakersUNKNOWN OPCARE9
Jul 9, 2011·Current Opinion in Supportive and Palliative Care·Natasja J H RaijmakersAgnes van der Heide
Mar 31, 2012·Journal of Pain and Symptom Management·Marlene Z CohenEduardo Bruera
Jul 18, 2012·Current Opinion in Supportive and Palliative Care·Rony DevEduardo Bruera
Nov 22, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eduardo BrueraKenneth Tarleton
Sep 12, 2014·Current Opinion in Supportive and Palliative Care·Nobuhisa NakajimaToshimichi Nakaho

❮ Previous
Next ❯

Citations

Oct 4, 2020·Current Opinion in Supportive and Palliative Care·Yi L Hwa, Michelle R Kull
Mar 6, 2021·Journal of Palliative Medicine·Peter StrangStaffan Lundström

❮ Previous
Next ❯

Software Mentioned

SPSS ( Statistical Package for the Social Sciences )
Survey Monkey

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

JAMA : the Journal of the American Medical Association
Tijdschrift Voor Diergeneeskunde
Iaira Boissevain
Revue française de transfusion et immuno-hématologie
G GerardJ Guimbretiere
© 2022 Meta ULC. All rights reserved